FSH receptor-targeted autologous T cell therapy

· H. Lee Moffitt Cancer Center and Research Institute

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FSH receptor-targeted autologous T cell therapy, covering 2025-12-05 to 2025-12-05. Get the full timeline:

Most recent: Clinical Trial Update: Infusion of Autologous T Cells Engineered to Target FSH Receptor in Recurrent Ovarian Cancer [Phase 1]